AR220838A1 - Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna - Google Patents

Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna

Info

Publication number
AR220838A1
AR220838A1 AR280860A AR28086080A AR220838A1 AR 220838 A1 AR220838 A1 AR 220838A1 AR 280860 A AR280860 A AR 280860A AR 28086080 A AR28086080 A AR 28086080A AR 220838 A1 AR220838 A1 AR 220838A1
Authority
AR
Argentina
Prior art keywords
procedure
influenza
preparing
viruses
virus
Prior art date
Application number
AR280860A
Other languages
English (en)
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR220838(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Lab filed Critical Cutter Lab
Application granted granted Critical
Publication of AR220838A1 publication Critical patent/AR220838A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AR280860A 1979-05-15 1980-04-30 Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna AR220838A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (1)

Publication Number Publication Date
AR220838A1 true AR220838A1 (es) 1980-11-28

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
AR280860A AR220838A1 (es) 1979-05-15 1980-04-30 Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna

Country Status (13)

Country Link
EP (1) EP0019218B2 (es)
JP (1) JPS55153723A (es)
AR (1) AR220838A1 (es)
AT (1) ATE16454T1 (es)
AU (1) AU535804B2 (es)
CA (1) CA1122527A (es)
DE (1) DE3071225D1 (es)
DK (1) DK154749C (es)
ES (1) ES8104405A1 (es)
IL (1) IL60063A0 (es)
NO (1) NO801443L (es)
RO (1) RO79525B (es)
YU (1) YU41923B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
DK0791055T3 (da) * 1994-11-10 2012-04-16 Baxter Healthcare Sa Fremgangsmåde til fremstilling af biologiske produkter i proteinfri kultur
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
WO1996015232A1 (en) * 1994-11-16 1996-05-23 St. Jude Children's Research Hospital Novel replication process
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE10144906B4 (de) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
JP2008519042A (ja) 2004-11-03 2008-06-05 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド インフルエンザワクチン接種
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EP2396032B1 (en) 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (es) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
DK212580A (da) 1980-11-16
YU41923B (en) 1988-02-29
ES491517A0 (es) 1981-04-01
YU126580A (en) 1983-12-31
RO79525A (ro) 1984-07-17
DE3071225D1 (en) 1985-12-19
EP0019218A2 (de) 1980-11-26
JPH0124769B2 (es) 1989-05-15
IL60063A0 (en) 1980-07-31
AU5824480A (en) 1980-11-20
EP0019218B2 (de) 1995-03-01
DK154749C (da) 1989-05-16
EP0019218A3 (en) 1981-03-25
JPS55153723A (en) 1980-11-29
CA1122527A (en) 1982-04-27
NO801443L (no) 1980-11-17
DK154749B (da) 1988-12-19
ES8104405A1 (es) 1981-04-01
RO79525B (ro) 1984-09-30
AU535804B2 (en) 1984-04-05
ATE16454T1 (de) 1985-11-15
EP0019218B1 (de) 1985-11-13

Similar Documents

Publication Publication Date Title
AR220838A1 (es) Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
NO790192L (no) Mikroporoest, trykkfoelsomt klebemiddel-belagt arkmateriale, samt fremgangsmaate for dets fremstilling
DK156765C (da) Fremgangsmaade til fremstilling af et liposomforstadium, som kan dispergeres i et egnet vandigt medium til fremstilling af et vandigt liposompraeparat
ES511668A0 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
TR20790A (tr) Suebstitueye fenoksibenziloksikarbonil tuerevleri,bunlarin hazirlanisi icin usuller ve bunlarin ensektisidler ve akarisidler olarak kullanilmalari
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
DK562281A (da) Fremgangsmaade mikroorgansimer og kulturmedium til fremstilling af antibioteket a-4696 som kompleks eller enkelte faktorer eller pharmaceutisk acceptable syreadditionssalte deraf samt kompleksets anvendelse som vaekstfremmende middel
BR7900752A (pt) Derivados de fenilpiperazina,processo para sua preparacao,medicamentos,e uso dos ditos derivados
SE433304B (sv) Farmaceutiska preparat med terapeutiska, speciellt anti- androgena och schistosomicida egenskaper
DK267979A (da) Fremgangsmaade til fremstilling af aryloxypropanolaminer
DK488180A (da) Tetrazolyloxycarboxylsyreamider fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
ES495939A0 (es) Un procedimiento de preparacion de una vacuna de virus vivosde la peritonitis infecciosa de los felinos
AR216080A1 (es) Derivados de 4-halo-dihidropirano,utiles como intermediarios en la preparacion de gamma-pironas,procedimiento para su preparacion y procedimiento para preparar una gamma-pirona partiendo de dichos intermediarios
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
AR218689A1 (es) Procedimiento para preparar una fibra de polimero de acrilonitrilo y la fibra resultante
DK53879A (da) N-azolylalkyl-halogenacetanilider fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider
AR230637A1 (es) Procedimiento para preparar nuevas fenilquinolicidinas 2-substituidas,e intermediarios para su uso exclusivo en el procedimiento
AR218134A1 (es) Procedimiento para la preparacion de una solucion acuosa,esteril y estable,de cisplatina
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
DK151811C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
ES494598A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
DK218483A (da) Halogenpropargylformamider, fremgangsmaade til fremstilling heraf samt deres anvendelse som midler til bekaempelse af skadelige organismer
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
IT8019070A0 (it) Oligopeptidi trifluorometilati, loro procedimento di preparazione eloro applicazione terapeutica